Update on clinical trials for myeloproliferative neoplasms
How can fatigue be recognized and managed?
MPD-RC 112 trial of pegylated interferon alpha-2a for polycythemia vera & essential thrombocythemia
Interferons: a promising potential therapy for MPN
Ruben A. Mesa
Predicting resistance to therapy in CLL